Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: A single photon emission computed tomography imaging study

Ruth Djaldetti, Mordechai Lorberboym, Yuval Karmon, Therese A. Treves, Ilan Ziv, Eldad Melamed

Research output: Contribution to journalArticlepeer-review

Abstract

Molecular imaging studies of Parkinson's disease (PD) progression mostly focus on the first 5 years after disease onset, demonstrating rapid initial nigrostriatal neuronal loss. The fate of residual functional dopaminergic nerve terminals in patients with long-standing PD has not yet been specifically explored. Therefore, we performed [123I]-FP-CIT single photon emission computed tomography (SPECT) in 15 patients with very long-standing PD (mean disease duration 20.6 ± 6.3 years). Measurable uptake of [123I]-FP-CIT was still detected in the striata of all patients. As seen in early stages, reduction of tracer uptake in the putamen was more prominent than in the caudate nucleus. Asymmetry in tracer uptake between the two putamen and caudate nuclei was preserved. These findings indicate that degeneration of dopaminergic neurons in PD is not total even after many years of illness. Data should be considered in exploring underlying causes of progressive loss of nigrostriatal dopaminergic neurons and development of future novel dopaminergic therapeutic strategies in PD.

Original languageEnglish
Pages (from-to)327-330
Number of pages4
JournalMovement Disorders
Volume26
Issue number2
DOIs
StatePublished - 1 Feb 2011

Keywords

  • Dopamine transporters scan
  • Long standing
  • Parkinson's disease
  • Single photon emission computed tomography

Fingerprint

Dive into the research topics of 'Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: A single photon emission computed tomography imaging study'. Together they form a unique fingerprint.

Cite this